1. Home
  2. AWRE vs SLGL Comparison

AWRE vs SLGL Comparison

Compare AWRE & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

N/A

Current Price

$1.19

Market Cap

24.6M

Sector

Technology

ML Signal

N/A

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$63.06

Market Cap

218.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AWRE
SLGL
Founded
1986
1997
Country
United States
Israel
Employees
80
28
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6M
218.9M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
AWRE
SLGL
Price
$1.19
$63.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $110.00
AVG Volume (30 Days)
31.7K
★ 52.7K
Earning Date
04-29-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$223.84
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$27.00
52 Week High
$2.84
$97.97

Technical Indicators

Market Signals
Indicator
AWRE
SLGL
Relative Strength Index (RSI) 47.72 45.68
Support Level $1.13 $62.21
Resistance Level $1.36 $67.85
Average True Range (ATR) 0.06 3.08
MACD -0.01 0.11
Stochastic Oscillator 35.51 58.87

Price Performance

Historical Comparison
AWRE
SLGL

About AWRE Aware Inc.

Aware Inc provides biometric identity and authentication solutions. Its Awareness Platform transforms biometric data into actionable intelligence, allowing its clients to verify identities and authenticate access and transactions. The company's products span multiple biometric modalities, including fingerprint, face, iris, and voice. It offers: a broad range of biometrics software products and solutions, including platforms like AwareSDK, AwareABIS, AFIX Suite of Products, Awareness Platform, and WebEnroll; software components such as SDKs, APIs, and applications that customers use to develop their systems into more effective solutions; and several program management and software engineering services. Aware earns maximum revenue from the U.S., followed by the UK and the rest of the world.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: